Insight Molecular Diagnostics Inc. Inventory Write-down
Insight Molecular Diagnostics Inc. (IMDX) reported Inventory Write-down of $123.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. inventory write-down for the quarter ending 2025-12-31 was -$10.00K.
- Insight Molecular Diagnostics Inc. inventory write-down for the quarter ending 2025-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. inventory write-down for the quarter ending 2024-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. inventory write-down for the quarter ending 2024-06-30 was -$60.97M.
- Insight Molecular Diagnostics Inc. inventory write-down for fiscal 2023 was $139.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123.00K 10-Q · filed 2026-08-10 | |||||
| 2025-12-31 | -$10.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-10 | -$10.00K derived: sum of 2 quarters · filed 2026-08-10 | $22.00K 10-Q · filed 2026-08-10 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $32.00K 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | $32.00K 10-Q · filed 2025-08-11 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$60.97M derived: sum of 2 quarters · filed 2024-11-12 | $32.00K 10-Q · filed 2024-11-12 | $32.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2024-06-30 | -$60.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $32.00K 10-Q · filed 2024-08-08 | $32.00K derived: sum of 3 quarters · filed 2025-05-12 | -$29.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2024-03-31 | $61.00M 10-Q · filed 2025-05-12 | $61.00K 10-Q · filed 2024-05-15 | $61.00M derived: sum of 2 quarters · filed 2025-05-12 | $60.94M derived: sum of 3 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$61.00K derived: sum of 2 quarters · filed 2025-03-24 | $139.00K 10-K · filed 2025-03-24 | $400.00K 10-Q · filed 2023-05-15 | ||
| 2023-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $139.00K 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |